View in EDS HTML Full Text PDF Full Text

Safety and Efficacy of HexaBody‐DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity.

Saved in:
Bibliographic Details
Title: Safety and Efficacy of HexaBody‐DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity.
Authors: Overdijk, Marije B.1 (AUTHOR) mok@genmab.com, Strumane, Kristin1 (AUTHOR), Plummer, Ruth2 (AUTHOR), LoRusso, Patricia3 (AUTHOR), Rodon Ahnert, Jordi4 (AUTHOR), Banerji, Udai5 (AUTHOR), Garralda, Elena6 (AUTHOR), Calvo, Emiliano7 (AUTHOR), Si, Han8 (AUTHOR), Hoevenaars, Naomi1 (AUTHOR), Mortensen, Jens Thing9 (AUTHOR), Bosgra, Sieto1 (AUTHOR), Malmberg, Anders9 (AUTHOR), Ellekilde‐Pedersen, Merete9 (AUTHOR), Ramirez‐Andersen, Teresa9 (AUTHOR), Diamantopoulou Reiter, Panagiota9 (AUTHOR), Favaro, Elena9 (AUTHOR), Forssmann, Ulf9 (AUTHOR), Breij, Esther C. W.1 (AUTHOR), Jure‐Kunkel, Maria8 (AUTHOR)
Source: CTS: Clinical & Translational Science. Jun2026, Vol. 19 Issue 6, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.70546